'מערכת אימד'Highlights
• Brexpiprazole is an adjunctive therapy for treatment of MDD.
• Anxiety symptoms are prevalent in MDD and associated with greater illness severity.
• We investigated brexpiprazole in patients with MDD and anxious distress.
• Brexpiprazole was efficacious in patients with MDD with/without anxious distress.
Roger S. McIntyre, Emmanuelle Weiller, Peter Zhang, Catherine Weiss,
Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials,
Journal of Affective Disorders, Volume 201, 2016, Pages 116-123, ISSN 0165-0327,
https://doi.org/10.1016/j.jad.2016.05.013.
Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials,
Journal of Affective Disorders, Volume 201, 2016, Pages 116-123, ISSN 0165-0327,
https://doi.org/10.1016/j.jad.2016.05.013.